Expanding upon this, we hypothesized that the active hormonal metabolite of vitamin D, 1,25-dihydroxyvitamin D3 (1,25D), may influence the expression of other putative IBS candidate genetic biomarkers, similar to the role of vitamin D in modulating TPH1 expression. Here, TPH1 is linked to irritable bowel syndrome.